Amneal Pharmaceuticals, Inc. (AMRX)
17.48
-0.06
(-0.34%)
USD |
NASDAQ |
Aug 31, 16:00
17.48
0.00 (0.00%)
After-Hours: 19:22
Amneal Pharmaceuticals Total Long Term Debt (Quarterly) : 2.680B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.680B |
| March 31, 2026 | 2.685B |
| December 31, 2025 | 2.678B |
| September 30, 2025 | 2.675B |
| June 30, 2025 | 2.281B |
| March 31, 2025 | 2.277B |
| December 31, 2024 | 2.480B |
| September 30, 2024 | 2.492B |
| June 30, 2024 | 2.533B |
| March 31, 2024 | 2.554B |
| December 31, 2023 | 2.559B |
| September 30, 2023 | 2.716B |
| June 30, 2023 | 2.726B |
| March 31, 2023 | 2.741B |
| December 31, 2022 | 2.777B |
| September 30, 2022 | 2.787B |
| June 30, 2022 | 2.804B |
| March 31, 2022 | 2.856B |
| December 31, 2021 | 2.866B |
| September 30, 2021 | 2.875B |
| June 30, 2021 | 2.909B |
| March 31, 2021 | 2.913B |
| December 31, 2020 | 2.939B |
| September 30, 2020 | 2.950B |
| June 30, 2020 | 2.962B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.967B |
| December 31, 2019 | 2.752B |
| September 30, 2019 | 2.757B |
| June 30, 2019 | 2.767B |
| March 31, 2019 | 2.777B |
| December 31, 2018 | 2.691B |
| September 30, 2018 | 2.797B |
| June 30, 2018 | 2.780B |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 1.484B |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 782.91M |
| December 31, 2016 | 831.26M |
| September 30, 2016 | 830.08M |
| June 30, 2016 | 435.26M |
| March 31, 2016 | 429.88M |
| December 31, 2015 | 424.60M |
| September 30, 2015 | 530.41M |
| June 30, 2015 | 581.39M |
| March 31, 2015 | 417.35M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Liquidia Corp. | 182.90M |
| Eli Lilly & Co. | 49.62B |
| Viatris, Inc. | 13.51B |
| Pfizer Inc. | 63.10B |
| Indivior Pharmaceuticals, Inc. | 500.00M |